DanCann Pharma A/S (NGM: DANCAN)

DanCann Pharma Revenue

DanCann Pharma had revenue of 3.86M DKK in the quarter ending June 30, 2024, with 37.91% growth. This brings the company's revenue in the last twelve months to 8.22M, up 3.55% year-over-year. In the year 2023, DanCann Pharma had annual revenue of 7.15M, down -0.50%.

• Revenue (ttm): 8.22M DKK
• Revenue Growth: +3.55%
• P/S Ratio: 0.43
• Revenue / Employee: 685.00K DKK
• Employees: 12
• Market Cap: 12.00M SEK

Revenue Chart

* This company reports financials in DKK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	7.15M	-36.00K	-0.50%
Dec 31, 2022	7.19M	4.88M	211.89%
Dec 31, 2021	2.31M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-421.80K	-	-